Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 119 Schemes (29.88%)
Foreign Institutions
Held by 338 Foreign Institutions (18.63%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
2,007 Million
(Quarterly Results - Mar 2026)
Net Profit:
13 Million
Pharmaceuticals & Biotechnology
USD 10,888 Million (Small Cap)
5.00
NA
0.00%
0.84
-999,999.00%
2.16






